Log in to save to my catalogue

Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity

Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_citationtrail_10_1126_science_aae0477

Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity

About this item

Full title

Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity

Publisher

American Association for the Advancement of Science

Journal title

Science (American Association for the Advancement of Science), 2016-07, Vol.353 (6297), p.399-403

Language

English

Formats

Publication information

Publisher

American Association for the Advancement of Science

More information

Scope and Contents

Contents

Cancers often evade immune surveillance by adopting peripheral tissue–tolerance mechanisms, such as the expression of programmed cell death ligand 1 (PD-L1), the inhibition of which results in potent antitumor immunity. Here, we show that cyclindependent kinase 5 (Cdk5), a serine-threonine kinase that is highly active in postmitotic neurons and in...

Alternative Titles

Full title

Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_citationtrail_10_1126_science_aae0477

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_citationtrail_10_1126_science_aae0477

Other Identifiers

ISSN

0036-8075

E-ISSN

1095-9203

DOI

10.1126/science.aae0477

How to access this item